I now have enough comprehensive information from Goodman & Gilman's and Harrison's to give a thorough, practical OPD guide. Let me compile this into a complete, well-organized answer.
🩺 Practical OPD Guide: Starting Anti-Diabetic Drugs
Based on Goodman & Gilman's Pharmacological Basis of Therapeutics & Harrison's Principles of Internal Medicine (2025)
First: Understand the Pattern Before Starting a Drug
| Finding | What it means | What to target |
|---|
| Fasting glucose high (FBG >126) | Liver making too much glucose overnight | Drugs that reduce hepatic glucose production |
| PP glucose high (2hr >200, but FBG near normal) | Poor insulin response to meals | Drugs that boost mealtime insulin or slow carb absorption |
| Both high | Both problems together | Usually need combination |
DRUG-BY-DRUG BREAKDOWN
1. 🟢 METFORMIN — Your First Drug, Almost Always
Cost: ₹2–5/day (generic) — very affordable
Mechanism: Reduces liver glucose output (suppresses gluconeogenesis). Does NOT stimulate insulin.
Who to start:
- Virtually every newly diagnosed T2DM patient as first-line (Goodman & Gilman's, p.1054)
- Overweight/obese patients especially
- Young patients
- IGT (pre-diabetes) — delays progression to diabetes
How to start:
- 500 mg with dinner, then after 1–2 weeks add 500 mg with breakfast
- Titrate up to 1000 mg BD (max 2000–2550 mg/day)
- Take with food — reduces GI side effects
OPD case:
Patient: 45M, FBG 160, PP 240, BMI 28, no other disease
Start: Metformin 500 mg BD with meals, increase to 1000 mg BD in 4 weeks. Review HbA1c at 3 months.
Hypoglycemia? ❌ NO — very safe, does not cause hypoglycemia alone
Weight? ✅ Neutral to mild weight LOSS
Side effects: Nausea, bloating, diarrhea (start low, go slow); rarely lactic acidosis if renal failure
Avoid if: eGFR <30, dehydration, contrast dye procedure, liver failure
2. 🟡 SULFONYLUREAS — Cheap, Effective, but Caution
Cost: ₹1–3/day (generic) — very affordable
Drugs: Glipizide, Glibenclamide (Glyburide), Gliclazide, Glimepiride, Glibenclamide
Mechanism: Force the pancreatic beta cells to secrete insulin regardless of blood glucose.
Who to use:
- When metformin alone is not enough
- Lean/thin diabetic patients (not overweight — weight gain is an issue)
- High fasting glucose mainly (they work on basal insulin release)
- Gliclazide / Glimepiride preferred (safer, less hypoglycemia than glibenclamide)
How to start:
- Glimepiride: 1–2 mg once daily with breakfast
- Gliclazide MR: 30–60 mg once daily with breakfast
- Glibenclamide: 2.5 mg OD with breakfast (old drug, avoid in elderly)
OPD cases:
Case 1: 55M, FBG 200, PP 290, not obese, metformin not sufficient
Add: Glimepiride 1 mg OD with breakfast. Counsel about hypoglycemia.
Case 2: 70F, HbA1c 9.5%, on metformin
Prefer Gliclazide MR 30 mg OD — safer in elderly, less hypoglycemia than glibenclamide
Hypoglycemia? ✅ YES — this is the main risk. Educate patient to carry sugar/glucose.
Weight? ⬆️ GAIN 1–3 kg (stimulates insulin → fat storage)
Avoid if: Elderly on glibenclamide, CKD (glipizide/gliclazide MR safer in CKD), sulfa allergy
3. 🔴 GLITAZONES (Pioglitazone) — Insulin Sensitizers
Cost: ₹10–15/day — affordable
Mechanism: Activates PPARγ → improves insulin sensitivity in fat, muscle, liver (Goodman & Gilman's, p.1055)
Who to use:
- Insulin resistant patients (metabolic syndrome, PCOS, NAFLD)
- Patients where metformin is not tolerated
- High PP glucose pattern (good sensitizer)
- Type 2 DM with NASH/fatty liver (pioglitazone actually helps NAFLD)
How to start:
- Pioglitazone 15 mg OD → increase to 30 mg OD after 4 weeks
- Onset is SLOW — full effect in 1–3 months
OPD case:
Patient: 48F, T2DM with NAFLD on ultrasound, BMI 31, FBG 175
Add: Pioglitazone 15 mg OD — benefits both diabetes and fatty liver
Hypoglycemia? ❌ NO (when used alone or with metformin)
Weight? ⬆️⬆️ GAIN significantly (fluid retention + fat redistribution)
Side effects: Edema, weight gain, increased fracture risk (women), possible bladder cancer risk with long-term use (controversial)
Avoid if: Heart failure, osteoporosis, active bladder cancer
4. 🔵 DPP-4 INHIBITORS (Gliptins) — Safe but Expensive
Cost: ₹30–60/day — moderately expensive
Drugs: Sitagliptin, Vildagliptin, Saxagliptin, Teneligliptin (cheapest), Alogliptin
Mechanism: Block DPP-4 enzyme → GLP-1 levels rise → glucose-dependent insulin release + glucagon suppression
Who to use:
- Elderly patients (very safe, no hypoglycemia)
- CKD patients (most can be used with dose adjustment)
- When weight neutrality is important
- When patient can afford it
- High PP glucose mainly (works on mealtime glucose)
How to start:
- Sitagliptin 100 mg OD (50 mg if eGFR 30–50; 25 mg if <30)
- Teneligliptin 20 mg OD — cheapest gliptin, ₹15–20/day
- Vildagliptin 50 mg BD
OPD case:
Patient: 68M, T2DM, CKD stage 3 (eGFR 42), FBG 140, PP 230
Use: Sitagliptin 50 mg OD (dose-adjusted) + Metformin is borderline — use cautiously or replace with Teneligliptin
Hypoglycemia? ❌ NO (glucose-dependent mechanism — stops when glucose normal)
Weight? ✅ NEUTRAL — no weight change
Side effects: Nasopharyngitis, mild GI issues, rare pancreatitis (controversial)
5. 💧 SGLT2 INHIBITORS — Modern, Expensive but Cardio-Protective
Cost: ₹50–120/day — expensive
Drugs: Empagliflozin, Dapagliflozin, Canagliflozin
Mechanism: Block kidney glucose reabsorption → glucose spilled in urine → sugar lost, BP drops, weight drops
Who to use (especially important):
- T2DM + Heart failure → Empagliflozin or Dapagliflozin are life-saving (EMPA-REG, DAPA-HF trials)
- T2DM + CKD (Dapagliflozin reduces CKD progression — DAPA-CKD trial)
- T2DM + Obesity (causes 2–3 kg weight loss)
- Hypertension with T2DM (also lowers BP)
How to start:
- Empagliflozin 10 mg OD (morning, before food)
- Dapagliflozin 10 mg OD
- Canagliflozin 100 mg OD before first meal
OPD cases:
Case 1: 52M, T2DM + HbA1c 8.5%, recent heart failure with reduced EF
Must use: Empagliflozin 10 mg OD — reduces hospitalization and death in HF
Case 2: 58F, T2DM + CKD (eGFR 55, proteinuria), HbA1c 8%
Use: Dapagliflozin 10 mg OD — slows CKD progression
Hypoglycemia? ❌ NO (glucose-dependent)
Weight? ⬇️ LOSS (−2 to −3 kg)
Side effects: Genital fungal infections (especially women), UTI, DKA (rare, especially if stopping too early before surgery)
Avoid if: eGFR <45 (limited efficacy), recurrent UTI/candidiasis
6. 💉 GLP-1 RECEPTOR AGONISTS — Newest, Most Expensive
Cost: ₹150–500/day — very expensive
Drugs (injections): Semaglutide (Ozempic/Rybelsus), Liraglutide, Dulaglutide
Oral: Rybelsus (oral semaglutide) — new
Who to use:
- T2DM + Obesity (most powerful weight loss — 5–15 kg)
- T2DM + Cardiovascular disease (Liraglutide/Semaglutide reduce MACE)
- When patient can afford and tolerates injections
- HbA1c very high (>10%) with need for big glucose drop
How to start:
- Liraglutide 0.6 mg SC OD × 1 week → 1.2 mg → 1.8 mg
- Semaglutide weekly injection 0.25 mg × 4 weeks → 0.5 mg → 1 mg
OPD case:
Patient: 44F, BMI 38, T2DM + NAFLD + cardiovascular risk, HbA1c 9.5%, can afford
Start: Semaglutide 0.25 mg/week + Metformin. Will lose significant weight, improve liver, reduce CV risk.
Hypoglycemia? ❌ NO (alone)
Weight? ⬇️⬇️ MAJOR LOSS (best of all drug classes)
Side effects: Nausea, vomiting (common initially), pancreatitis (rare)
7. 🌾 ALPHA-GLUCOSIDASE INHIBITORS (Acarbose) — Postprandial Specialist
Cost: ₹10–20/day — affordable
Mechanism: Slows carbohydrate digestion in gut → blunts PP glucose spike
Who to use:
- Postprandial glucose mainly high, FBG near normal
- Indian diet (rice/roti heavy — lots of carbs)
- Elderly (very safe)
- Mild diabetes or pre-diabetes
How to start:
- Acarbose 25 mg OD with first bite of meal → increase to 25 mg TDS → max 100 mg TDS
OPD case:
Patient: 62F, FBG 115 (near normal), PP 220, BMI 24, no other drugs
Start: Acarbose 25 mg with each meal — perfectly targeted for her postprandial problem
Hypoglycemia? ❌ NO
Weight? ✅ NEUTRAL to mild loss
Side effects: Flatulence, bloating, diarrhea — common, often limiting
Avoid if: GI motility disorders, IBD, significant renal impairment
8. ⚡ MEGLITINIDES (Repaglinide) — Mealtime Sugar
Cost: ₹15–25/day — moderate
Mechanism: Short-acting insulin secretagogue — only works at mealtimes
Who to use:
- Isolated postprandial hyperglycemia
- Irregular meal schedule (taken only when eating — flexible)
- CKD (repaglinide safe in CKD)
- When sulfonylurea causes too much hypoglycemia
OPD case:
Patient: 50M, FBG 125, PP 240, irregular eating schedule (skips meals sometimes)
Use: Repaglinide 0.5 mg before each meal he eats — no meal, no tablet
Hypoglycemia? ✅ YES (but less than sulfonylureas — shorter acting)
Weight? ⬆️ Mild gain
SIDE EFFECT SUMMARY TABLE
| Drug | Hypoglycemia | Weight | Cost |
|---|
| Metformin | ❌ No | ↔ Neutral/↓ | ₹₹ Very cheap |
| Sulfonylurea | ✅ YES | ⬆️ Gain | ₹ Very cheap |
| Pioglitazone | ❌ No | ⬆️⬆️ Big gain | ₹₹ Cheap |
| DPP-4 inhibitors | ❌ No | ↔ Neutral | ₹₹₹ Moderate |
| SGLT2 inhibitors | ❌ No | ⬇️ Loss | ₹₹₹₹ Expensive |
| GLP-1 agonists | ❌ No | ⬇️⬇️ Big loss | ₹₹₹₹₹ Very expensive |
| Acarbose | ❌ No | ↔ Neutral | ₹₹ Cheap |
| Repaglinide | ✅ Mild | ⬆️ Mild gain | ₹₹ Moderate |
AFFORDABLE COMBINATIONS (Budget Patients)
Combination 1 — Cheapest effective combo
Metformin 500–1000 mg BD + Glimepiride 1–2 mg OD
- Cost: ₹3–8/day
- Good for: Most newly diagnosed T2DM with FBG + PP both elevated
- Watch: Counsel about hypoglycemia with glimepiride
Combination 2 — Fasting high, no weight issues
Metformin BD + Gliclazide MR 60 mg OD
- Cost: ₹5–10/day
- Good for: Elderly, better than glibenclamide
Combination 3 — PP high, affordable
Metformin BD + Acarbose 25 mg TDS with meals
- Cost: ₹5–12/day
- Good for: Postprandial high, Indian high-carb diet, obese
Combination 4 — Both FBG + PP high, affordable
Metformin + Glimepiride + Pioglitazone 15 mg (fixed-dose triple combo available)
- Cost: ₹10–20/day
- Good for: HbA1c >9%, obese insulin-resistant patients
EXPENSIVE COMBINATIONS (Patients Who Can Afford)
Combo A — Diabetic + Obese
Metformin + Empagliflozin 10 mg + Semaglutide weekly
- Best for weight loss + glucose control + CV protection
Combo B — Diabetic + Heart Failure
Metformin + Empagliflozin 10 mg OD
- Reduces HF hospitalization and mortality
Combo C — Diabetic + CKD
Metformin (if eGFR >45) + Dapagliflozin 10 mg + Teneligliptin 20 mg
- Slows CKD progression, safe in mild-moderate CKD
Combo D — Elderly T2DM, avoid hypoglycemia
Metformin 500 BD + Teneligliptin 20 mg OD (or Sitagliptin 100 mg OD)
- Very safe, no hypoglycemia, well tolerated
QUICK OPD DECISION FLOWCHART
NEW T2DM PATIENT
│
▼
Start METFORMIN 500 mg BD (always, unless contraindicated)
│
3 months → Review HbA1c / FBG / PP
│
┌────┴────┐
FBG high PP high Both high
│ │ │
Add Add Add SU or
Glimepiride Acarbose Pioglitazone
or SU or DPP4 or DPP4
│
If still uncontrolled (HbA1c >8.5%)
│
Add 3rd agent OR consider Insulin
│
If HbA1c >10% at diagnosis → Start insulin + OHA together
IMPORTANT CLINICAL PEARLS FOR OPD
-
Never start glibenclamide in elderly — too long-acting, deadly hypoglycemia. Use gliclazide MR or glimepiride.
-
Metformin + fasting glucose: Metformin mainly reduces fasting glucose (reduces hepatic glucose production overnight). It's particularly good for elevated FBG.
-
Acarbose / Repaglinide for PP glucose: These specifically target postprandial spikes. Great for patients with near-normal FBG but elevated PP.
-
Pioglitazone + edema: Always ask about heart failure before prescribing. Don't use if NYHA Class 3–4 HF.
-
If patient can't afford anything: Metformin + Glimepiride combo tablet (cheap, widely available) is your workhorse. Add Acarbose for PP if needed.
-
Always counsel on hypoglycemia: Any patient on sulfonylurea or insulin must know to eat regularly and carry sugar. Hypoglycemia is more dangerous than mild hyperglycemia.
-
SGLT2 inhibitors before surgery: STOP 3–4 days before any procedure — risk of euglycemic DKA.
-
Renal dose adjustments:
- Metformin: Stop if eGFR <30; reduce if eGFR 30–45
- Glipizide/Gliclazide: Relatively safe in CKD
- Sitagliptin: Dose reduce in CKD
- Repaglinide: Safe in CKD
- SGLT2i: Avoid if eGFR <45
SUMMARY: WHICH PATIENT GETS WHAT
| Patient Profile | First Choice | Add-On | Avoid |
|---|
| Newly diagnosed T2DM, any | Metformin | — | — |
| Obese, high both | Metformin | SGLT2i or GLP-1 | Glitazone, SU |
| Thin, high both | Metformin | Sulfonylurea | — |
| High FBG, normal PP | Metformin | Sulfonylurea | — |
| Normal FBG, high PP | Metformin | Acarbose or DPP4 | — |
| Elderly | Metformin | DPP4 inhibitor | Glibenclamide |
| CKD | Metformin (if eGFR >45) | DPP4 or Repaglinide | SGLT2i if eGFR<45 |
| Heart failure | Metformin | SGLT2 inhibitor | Glitazone, SU |
| NAFLD/fatty liver | Metformin | Pioglitazone | — |
| PCOS with diabetes | Metformin | GLP-1 or DPP4 | — |
| Can't afford much | Metformin | Sulfonylurea | Expensive drugs |
| Budget moderate | Metformin + SU | Acarbose or Pioglitazone | — |
| Budget good | Metformin | DPP4 or SGLT2i | — |
Sources: Goodman & Gilman's Pharmacological Basis of Therapeutics, 14th Ed.; Harrison's Principles of Internal Medicine 22E (2025); Brenner & Rector's The Kidney